Metabolic syndrome components are associated with future medical costs independent of cardiovascular hospitalization and incident diabetes

Metabolic Syndrome and Related Disorders

Volumn 9, Issue 2, 2011, Pages 127-133

  Nichols, Gregory A ^a   Moler, Edward J ^b  

^a CENTER FOR HEALTH RESEARCH   (United States)

^b Tethys Bioscience Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; DRUG COST; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEALTH CARE COST; HOSPITAL COST; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; SEX; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

ADULT; AGED; BODY MASS INDEX; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HUMANS; HYPERTENSION; LIPOPROTEINS, HDL; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; OREGON; TRIGLYCERIDES;

EID: 79953120659     PISSN: 15404196     EISSN: None     Source Type: Journal    
DOI: 10.1089/met.2010.0105     Document Type: Article

References (22)

1. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Clee-man JI, Donato KA, Fruchart J-C, James PT, Loria CM, Smith SC Jr. Harmonizing the Metabolic Syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis So-ciety; and International Association for the Study of Obesity. Circulation 2009;120:1640-1645.
2. Simmons RK, Alberti KGMM, Gale EAM, Colagiuri S, Tuomilehto J, Qiao Q, Ramachandran A, Tajima N, Brajko-vich Mirchov I, Ben-Nakhi A et al. The Metabolic Syndrome: Useful Concept or Clinical Tool? Report of a WHO Expert Consultation. Diabetologia 2010;53:600-605.
3. Borch-Johnsen K, Wareham N. The rise and fall of the metabolic syndrome. Diabetologia 2010;53:597-599.
4. Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005;15;112:3066-3072. (Pubitemid 43113437)
5. Ford ES. Risks for all-cause mortality, cardiovascular dis-ease, and diabetes associated with the metabolic syndrome: A summary of the evidence. Diabetes Care 2005;28:1769-1778. (Pubitemid 40923091)
6. Nichols GA, Moler EJ. Diabetes incidence for all possible combinations of metabolic syndrome components. Diabetes Res Clin Pract 2010;90:115-121.
7. Nichols GA, Brown JB. Higher medical costs accompany impaired fasting glucose. Diabetes Care 2005;28:2223-2229. (Pubitemid 41242472)
8. Thompson D, Brown JB, Nichols GA, Elmer PJ, Oster G Body mass index and future healthcare costs: a retrospective cohort study. Obesity Res 2001;9:210-218. (Pubitemid 33600282)
9. Curtis LH, Hammill BG, Bethel MA, Anstrom KJ, Gottdiener JS, Schulman KA. Costs of the metabolic syndrome in elderly individuals: Findings from the Cardiovascular Health Study. Diabetes Care 2007;30:2553-2558. (Pubitemid 47547792)
10. Boudreau DM, Malone DC, Raebel MA, Fishman PA, Ni-chols GA, Feldstein AC, Boscoe AN, Ben-Joseph RH, Magid DJ, Okamoto LJ. Health care utilization and costs by meta-bolic syndrome risk factors. Metab Syndr Relat Disord 2009; 7:304-314.
11. Wannamethee SG, Shaper AG, Lennon L, Morris RW. Me-tabolic syndrome vs. Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mel-litus. Arch Intern Med 2005;165:2644-2650. (Pubitemid 41785063)
12. Sattar N, Gaw A, Scherbakova O, Ford I, O'Reilly DStJ, Haffner SM, Isles C, Macfarlane PW, Packard CJ, Cobbe SM, Shepherd J. Metabolic syndrome with and without C-Reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003;108:414-419. (Pubitemid 36935533)
13. Hornbrook MC, Goodman MJ. Adjusting health benefit contributions to reflect risk. In: Hornbrook MC (ed). Ad-vances in Health Economics and Health Services Research. Greenwich, CT: JAI Press Inc.; 1991: 41-76.
14. Hornbrook MC, Goodman MJ, Fishman PA, Meenan RT, O'Keefe-Rosetti MC, Bachman DJ. Building health plan da-tabases to risk-adjust outcomes and payments. Intl J Quality Health Care 1998;10:531-538. (Pubitemid 29037246)
15. Tamariz L, Palacio A, Yang Y, Parris D, Ben-Joseph R, Florez H. Health economics perspective of the components of the cardiometabolic syndrome. J Clin Hypertens 2010;12:549-555.
16. Raebel MA, Malone DC, Conner DA, Xu S, Porter JA, Lanty FA. Health services use and health care costs of obese and nonobese individuals. Arch Intern Med 2004;164:2135-2140. (Pubitemid 39410803)
17. Wang G, Zhang Z, Ayala C Hospitalization costs associated with hypertension as a secondary diagnosis among insured pateints aged 18-64 years. Am J Hypertens 2010;23:275-281.
18. Chodick G, Porath A, Alapi H, Sella T, Flash S, Wood F, Shalev V. The direct medical costs of cardiovascular dis-eases, hypertension, diabetes, cancer, pregnancy and female infertility in a large HMO in Israel. Health Policy 2010;95:271-276.
19. American Diabetes Association. Economic costs of diabetes in the U.S. in 2007. Diabetes Care 2008;31:596-615.
20. National Heart LaBI. NHLBI Factbook Fiscal Year 2009. http://www nhlbi nih gov/about/factbook/toc htm 2010. Accessed at http://www.nhlbi.nih.gov/about/ factbook/toc.htm/.
21. Nichols GA, Glauber HS, Brown JB. Type 2 diabetes: In-cremental medical care costs during the first eight years preceding diagnosis. Diabetes Care 2000;23:1654-1659.
22. Nichols GA, Arondekar B, Herman WH. Complications of dysglycemia and medical costs associated with nondiabetic hyperglycemia. Am J Manag Care 2008;14:791-798.